Skip to main content
Chetan Bettegowda, MD, Neurosurgery, Lutherville, MD

Chetan Bettegowda MD

Neurosurgery•Lutherville, MD

Assistant Professor of Neurological Surgery, Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Join to View Full Profile

  • 10753 Falls RoadPavilion II, Suite 115Lutherville, MD 21093

  • Phone+1 410-955-6406

  • Fax+1 410-616-7231

Dr. Bettegowda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Bettegowda's Full ProfileAlready have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurological Surgery, 2006 - 2012
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineInternship, Transitional Year, 2005 - 2006
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2005

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2012 - 2026
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Subependymal Giant Cell Astrocytoma-like Astrocytoma: A Neoplasm with a Distinct Phenotype and Frequent Neurofibromatosis Type-1-Association  
    Murat Gokden, Fausto J Rodriguez, Mark Jentoft, Chetan Bettegowda, Caterina Giannini, Aditya Raghunathan, Doris Lin, Nature

Authored Content

  • The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018
  • The Radiographic Effects of Surgical Approach and Use of Retractors on the Brain After Anterior Cranial Fossa Meningioma ResectionJanuary 2018

Press Mentions

  • HMN 2025: How Experimental Blood Check Precisely Signifies Severity and Predicts Potential Restoration from Spinal Twine Harm
    HMN 2025: How Experimental Blood Check Precisely Signifies Severity and Predicts Potential Restoration from Spinal Twine HarmApril 1st, 2025
  • Experimental Blood Test Accurately Indicates Severity and Predicts Potential Recovery from Spinal Cord Injury
    Experimental Blood Test Accurately Indicates Severity and Predicts Potential Recovery from Spinal Cord InjuryMarch 31st, 2025
  • Assessing the Utilization of Palliative Care in Advanced NSCLC Patients with Brain Metastases
    Assessing the Utilization of Palliative Care in Advanced NSCLC Patients with Brain MetastasesNovember 27th, 2024
  • Join now to see all

Grant Support

  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapyJOHNS HOPKINS UNIVERSITY2023–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsJOHNS HOPKINS UNIVERSITY2018–2028
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System LymphomasJOHNS HOPKINS UNIVERSITY2022–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019UNIVERSITY OF FLORIDA2021–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidJOHNS HOPKINS UNIVERSITY2018–2025
  • Multi-omic CSF Assay for the Diagnosis of Brain CancersBELAY DIAGNOSTICS, LLC2024

Professional Memberships

Other Languages

  • Kannada

External Links

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Chetan Bettegowda, Dr. Chetan Bettegowda, MD, Dr. C Bettegowda